BeStock  
Stocks › Healthcare Plans › ELV

Elevance Health ELV

US equityMarket cap rank #233Healthcare Plans
$425.62 −$6.38 (-1.48%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $425.62 0.00%
Open$421.47
Prev close$432.00
Day range$421.47 – $430.69
Volume1.44M
Market cap$91.96B
P/E (TTM)18.1
Dividend yield1.61%

Earnings

Average move on report day±4.3%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+5.9%
Worst reaction-12.2%

Stock move on the day after each report

+0.3%2023/Q4+3.2%2024/Q1-5.8%2024/Q2-10.6%2024/Q3+2.7%2024/Q4+2.3%2025/Q1-12.2%2025/Q2-1.2%2025/Q3+5.9%2025/Q4+0.0%2026/Q1-8.5%2026/Q2-1.4%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q321 Oct 2026Pre Market±8.0%-1.37%Within range
2026/Q215 Jul 2026Pre Market±5.4%-8.54%Bigger than priced
2026/Q122 Apr 2026Pre Market±7.7%+0.03%Within range
2025/Q428 Jan 2026Pre Market±8.1%+5.86%Within range
2025/Q321 Oct 2025Pre Market±9.8%-1.22%Within range
2025/Q217 Jul 2025Pre Market±8.1%-12.22%Bigger than priced
2025/Q122 Apr 2025Pre Market±9.0%+2.26%Within range
2024/Q423 Jan 2025Pre Market±10.0%+2.72%Within range
2024/Q317 Oct 2024Pre Market±6.1%-10.59%Bigger than priced
2024/Q217 Jul 2024Pre Market±3.9%-5.82%Bigger than priced
2024/Q118 Apr 2024Pre Market±4.9%+3.19%Within range
2023/Q424 Jan 2024Pre Market±4.2%+0.32%Within range
2023/Q318 Oct 2023Pre Market±4.2%+0.78%Within range
2023/Q219 Jul 2023Pre Market±4.1%+4.40%Bigger than priced
2023/Q119 Apr 2023Pre Market±2.9%-5.33%Bigger than priced
2022/Q425 Jan 2023Pre Market±3.5%+3.57%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Health Benefits$43.36B 68.1%
  • CarelonRx$11.60B 18.2%
  • Carelon Services$7.71B 12.1%
  • Net investment income$1.04B 1.6%
  • Corporate & Other$6.00M 0.0%

Fundamentals

Full statements →

Latest reported quarter: Q3, ended Sep 2026

Revenue$51.43B+1.4% YoY
Net profit$1.34B+13.1% YoY
Diluted EPS$6.27+17.9% YoY
Free cash flow$1.00B+29.0% YoY
Operating cash flow$1.27B

Revenue, last 8 quarters

$45.4BDec '24$48.9BMar '25$49.8BJun '25$50.7BSep '25$49.7BDec '25$50.2BMar '26$50.5BJun '26$51.4BSep '26

Net profit, last 8 quarters

$413.0MDec '24$2.2BMar '25$1.7BJun '25$1.2BSep '25$546.0MDec '25$1.8BMar '26$1.5BJun '26$1.3BSep '26

Profitability & balance sheet

Net margin2.5%
Return on equity11.6%
Return on assets4.1%
Liabilities / assets65.0%
Total debt$30.76B
Free cash flow / sales3.2%

Discussion

No comments yet — be the first to weigh in on ELV.

Sign in to join the discussion.

Scroll to Top